Frazier Healthcare Partners Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 33
Professionals
  • Investments
  • 384
  • Portfolio
  • 49
  • Exits
  • 176
Exits

Frazier Healthcare Partners General Information

Description

Founded in 1991, Frazier Healthcare Partners is a provider of growth and venture capital to healthcare companies. The firm's Growth Buyout team invests in healthcare and pharmaceutical services, medical products, and related sectors. The Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation. It is based in Seattle, Washington.

Contact Information

Formerly Known As
Frazier Healthcare
Year Founded
1991
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
  • Two Union Square, 601 Union Street
  • Suite 3200
  • Seattle, WA 98101
  • United States
+1 (206) 000-0000

Frazier Healthcare Partners Investments (384)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Imago BioSciences 19-Nov-2020 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 3
00000000 11-Nov-2020 00000 00000 0000 Drug Delivery Startup 000000 00000 00.0
00000000 02-Oct-2020 0000000000 Diagnostic Equipment Generating Revenue 000 0000000
00000 000000 00000 22-Sep-2020 0000000000 Pharmaceuticals Generating Revenue 000000 00000 00
000 00000000000 27-Jul-2020 00000 00000 000.00 Drug Discovery Startup 0000000 00000
00000000 30-Jun-2020 00000 00000 00000 Drug Discovery Pre-Clinical Trials
000000 26-Jun-2020 0000 00000 Drug Discovery Generating Revenue/Not Profitable
0000000 00000000 27-May-2020 0000 00.00 Therapeutic Devices Generating Revenue/Not Profitable
Lengo Therapeutics 12-May-2020 Early Stage VC 0000 Drug Discovery Generating Revenue 000000 00000 00.0
Dascena 30-Apr-2020 Later Stage VC 0000 Outcome Management (Healthcare) Generating Revenue 00000 00000 00
You’re viewing 10 of 384 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Frazier Healthcare Partners Exits (174)

Company Name Exit Date Exit Type Exit Size
Iterum Therapeutics 26-Oct-2020 Public Investment 2nd Offering 000.00
000000 00000000000 16-Oct-2020 000 0000
000 000000 0000000 20-Aug-2020 0000000000
00000000 07-Aug-2020 000 00000
0000000 12-Jun-2020 000 00000
0000000 000 28-Feb-2020 000 00000
0000000 0000000000 31-Jan-2020 000 00000
0000000 13-Jan-2020 000000 0000000000 000.00
Aradigm 30-Oct-2019 Bankruptcy: Admin/Reorg
Phathom Pharmaceuticals 25-Oct-2019 IPO 00000
You’re viewing 10 of 174 exits. Get the full list »

Frazier Healthcare Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Frazier Healthcare Partners Team (118)

Name Title Deals Funds Boards Office
Thomas Hodge JD Senior Advisor Seattle, WA
Steve Bailey Chief Financial Officer & Partner Seattle, WA
Patrick Heron Managing General Partner, Life Sciences 00 0 0 Menlo Park, CA
Nader Naini Managing Partner 00 0 0 Seattle, WA
Brian Morfitt General Partner 00 0 0 Seattle, WA
You’re viewing 5 of 118 team members. Get the full list »

Frazier Healthcare Partners Co-Investors (142)

Name With Exits Lead Partner Series Industry
OrbiMed 6 0 0 Series chart Industry bar
Nan Fung Life Sciences 0 0 Series chart Industry bar
Novo Holdings 0 0 0 Series chart Industry bar
Vivo Capital 0 0 0 Series chart Industry bar
Longitude Capital 0 0 0 Series chart Industry bar
You’re viewing 5 of 142 co-investors. Get the full list »